2018 annual financial data

Viridian Therapeutics 2018 Net margin

Direct answer

Net margin was -389.97%.

Operating income was -33.08M USD and net income was -32.7M USD.
Operating cash flow was -26.84M USD.

Get free Viridian Therapeutics email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
8.39M USD
Operating income
-33.08M USD
Net income
-32.7M USD
Operating cash flow
-26.84M USD